213 related articles for article (PubMed ID: 28476614)
1. A strategy for bypassing the blood-brain barrier: Facial intradermal brain-targeted delivery via the trigeminal nerve.
Yu XC; Yang JJ; Jin BH; Xu HL; Zhang HY; Xiao J; Lu CT; Zhao YZ; Yang W
J Control Release; 2017 Jul; 258():22-33. PubMed ID: 28476614
[TBL] [Abstract][Full Text] [Related]
2. The involvement of perivascular spaces or tissues in the facial intradermal brain-targeted delivery.
Yang W; Jin BH; Chen YJ; Cao C; Zhu JZ; Zhao YZ; Yu XC; Li FZ
Drug Deliv; 2019 Dec; 26(1):393-403. PubMed ID: 30929532
[TBL] [Abstract][Full Text] [Related]
3. Intradermal injection of icariin-HP-β-cyclodextrin improved traumatic brain injury via the trigeminal epineurium-brain dura pathway.
Yang W; Han YH; Wang HC; Lu CT; Yu XC; Zhao YZ
J Drug Target; 2022 Jun; 30(5):557-566. PubMed ID: 35023434
[TBL] [Abstract][Full Text] [Related]
4. Direct nose to brain drug delivery via integrated nerve pathways bypassing the blood-brain barrier: an excellent platform for brain targeting.
Pardeshi CV; Belgamwar VS
Expert Opin Drug Deliv; 2013 Jul; 10(7):957-72. PubMed ID: 23586809
[TBL] [Abstract][Full Text] [Related]
5. Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration.
Thorne RG; Pronk GJ; Padmanabhan V; Frey WH
Neuroscience; 2004; 127(2):481-96. PubMed ID: 15262337
[TBL] [Abstract][Full Text] [Related]
6. Intranasal Drug Delivery: A Non-Invasive Approach for the Better Delivery of Neurotherapeutics.
Kumar H; Mishra G; Sharma AK; Gothwal A; Kesharwani P; Gupta U
Pharm Nanotechnol; 2017; 5(3):203-214. PubMed ID: 28521670
[TBL] [Abstract][Full Text] [Related]
7. Direct transport of VEGF from the nasal cavity to brain.
Yang JP; Liu HJ; Cheng SM; Wang ZL; Cheng X; Yu HX; Liu XF
Neurosci Lett; 2009 Jan; 449(2):108-11. PubMed ID: 18996442
[TBL] [Abstract][Full Text] [Related]
8. Intranasal delivery: circumventing the iron curtain to treat neurological disorders.
Jiang Y; Li Y; Liu X
Expert Opin Drug Deliv; 2015; 12(11):1717-25. PubMed ID: 26206202
[TBL] [Abstract][Full Text] [Related]
9. Delivery of immunoglobulin G antibodies to the rat nervous system following intranasal administration: Distribution, dose-response, and mechanisms of delivery.
Kumar NN; Lochhead JJ; Pizzo ME; Nehra G; Boroumand S; Greene G; Thorne RG
J Control Release; 2018 Sep; 286():467-484. PubMed ID: 30081144
[TBL] [Abstract][Full Text] [Related]
10. Improving brain drug targeting through exploitation of the nose-to-brain route: a physiological and pharmacokinetic perspective.
Badhan RK; Kaur M; Lungare S; Obuobi S
Curr Drug Deliv; 2014; 11(4):458-71. PubMed ID: 24655046
[TBL] [Abstract][Full Text] [Related]
11. [Evaluation of brain-targeted trendence of scutellarin nasal administration].
Shi S; Wu J; Dai W; Li C; Ge W
Zhongguo Zhong Yao Za Zhi; 2010 Sep; 35(18):2453-6. PubMed ID: 21141499
[TBL] [Abstract][Full Text] [Related]
12. Biomaterials-Enhanced Intranasal Delivery of Drugs as a Direct Route for Brain Targeting.
Marcello E; Chiono V
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834804
[TBL] [Abstract][Full Text] [Related]
13. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
14. Remote control of the permeability of the blood-brain barrier by magnetic heating of nanoparticles: A proof of concept for brain drug delivery.
Tabatabaei SN; Girouard H; Carret AS; Martel S
J Control Release; 2015 May; 206():49-57. PubMed ID: 25724273
[TBL] [Abstract][Full Text] [Related]
15. Reversible blood-brain barrier disruption by repeated transcranial focused ultrasound allows enhanced extravasation.
Yang FY; Lin YS; Kang KH; Chao TK
J Control Release; 2011 Feb; 150(1):111-6. PubMed ID: 21070825
[TBL] [Abstract][Full Text] [Related]
16. Drug Delivery and Targeting to the Brain Through Nasal Route: Mechanisms, Applications and Challenges.
Kashyap K; Shukla R
Curr Drug Deliv; 2019; 16(10):887-901. PubMed ID: 31660815
[TBL] [Abstract][Full Text] [Related]
17. Magnetic-resonance imaging for kinetic analysis of permeability changes during focused ultrasound-induced blood-brain barrier opening and brain drug delivery.
Chai WY; Chu PC; Tsai MY; Lin YC; Wang JJ; Wei KC; Wai YY; Liu HL
J Control Release; 2014 Oct; 192():1-9. PubMed ID: 24969355
[TBL] [Abstract][Full Text] [Related]
18. Highly site-selective transvascular drug delivery by the use of nanosecond pulsed laser-induced photomechanical waves.
Sato S; Yoshida K; Kawauchi S; Hosoe K; Akutsu Y; Fujimoto N; Nawashiro H; Terakawa M
J Control Release; 2014 Oct; 192():228-35. PubMed ID: 25102403
[TBL] [Abstract][Full Text] [Related]
19. Nose to brain transport pathways an overview: potential of nanostructured lipid carriers in nose to brain targeting.
Selvaraj K; Gowthamarajan K; Karri VVSR
Artif Cells Nanomed Biotechnol; 2018 Dec; 46(8):2088-2095. PubMed ID: 29282995
[TBL] [Abstract][Full Text] [Related]
20. Trigeminal pathways deliver a low molecular weight drug from the nose to the brain and orofacial structures.
Johnson NJ; Hanson LR; Frey WH
Mol Pharm; 2010 Jun; 7(3):884-93. PubMed ID: 20420446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
